Indication DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).

Contact a DUPIXENT Field Representative

Contact a DUPIXENT Field Representative

To connect with a DUPIXENT Field Representative regarding product-related questions, please fill in the required fields below.

To connect with a DUPIXENT Field Representative regarding product-related questions, please fill in the required fields below.